Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Larry Culp finally pulled the plug on General Electric (NYSE: GE ) stock, killing the 129-year old conglomerate that created the industrial age. Source: Jonathan Weiss / Shutterstock.com Ironically, the electr...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Integra LifeSciences Holdings Corporation (IART) Q3 2021 Earnings Conference Call November 02, 2021 8:30 AM ET Company Participants Mike Beaulieu – Director-Investor Relations Peter Arduini – President and Chief Executive Officer Glenn Coleman – Chief Operating Officer Ca...
Image source: The Motley Fool. Integra LifeSciences Holdings Corporation (NASDAQ: IART) Q3 2021 Earnings Call Nov 2, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Integra LifeSciences Holdings Corporation (IART) Q...
Integra LifeSciences (IART +7.6%) has recorded the biggest intra-day gain since Nov. 2020 after the company reported better-than-expected financials for Q3 2021 and raised the full-year guidance for adjusted earnings ahead of Street forecasts. Revenue for the quarter gained ~4.5% YoY on ...
Integra LifeSciences Holdings (NASDAQ:IART): Q3 Non-GAAP EPS of $0.86 beats by $0.14; GAAP EPS of $0.51 beats by $0.11. Revenue of $386.8M (+4.5% Y/Y) beats by $2.33M. Press Release For further details see: Integra LifeSciences Holdings EPS beats by $0.14, beats on revenue
Third Quarter 2021 Highlights Revenues of $386.9 million increased 4.5% on a reported basis and 6.7% on an organic basis compared to the prior year; GAAP earnings per diluted share of $0.51, compared to $0.38 in the third quarter of 2020; adjusted earnings per diluted share ...
Integra LifeSciences Holdings (NASDAQ:IART) is scheduled to announce Q3 earnings results on Tuesday, November 2nd, before market open. The consensus EPS Estimate is $0.72 (-10.0% Y/Y) and the consensus Revenue Estimate is $384.47M (+3.9% Y/Y). Over the last 2 years, IART has beaten EPS estima...
OTCQX:ACDVF,AHH,AME,APO,OTCQX:ARBKF,ARCB,ARNC,AROC,AVNS,BCC,BHC,BLD,BLMN,BP,CEIX,CEN,CMI,COP,CRSR,CTLT,DD,DEA,EL,EOLS,EPD,ESPR,ETN,ETRN,EXTR,FMS,OTCPK:FSNUF,GLDD,GLYC,GNRC,GPN,HEP,HSIC,IAA,IART,IDXX,IEP,INCY,INGR,IPGP,IT,KKR,KOPN,LCII,LDOS,LEA,LGIH,LPX,MGY,MIME,MLM,MMP,MPC,MPLX,MYGN,OTCQB:NLS...
Integra LifeSciences (NASDAQ:IART) has appointed Jan De Witte as President and CEO, and a member of its Board of Directors. De Witte will join Integra prior to the end of 2021. He succeeds Peter Arduini, who is stepping down to join GE Healthcare as President and CEO. Most recently, De Witte ...
News, Short Squeeze, Breakout and More Instantly...
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
Integra LifeSciences Holdings Corporation Website:
2024-07-30 10:00:08 ET Richard Newitter from Truist Financial issued a price target of $26.00 for IART on 2024-07-30 08:59:00. The adjusted price target was set to $26.00. At the time of the announcement, IART was trading at $24.59. The overall price target consensus is ...
2024-07-30 06:30:09 ET Citigroup analyst issues SELL recommendation for IART on July 30, 2024 03:24AM ET. The previous analyst recommendation was Neutral. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : SELL. Current...
2024-07-30 06:00:06 ET Joanne Wuensch from Citigroup issued a price target of $23.00 for IART on 2024-07-30 03:24:00. The adjusted price target was set to $23.00. At the time of the announcement, IART was trading at $25.42. The overall price target consensus is at $47.00...